Rhone-Poulenc Rorer Targets September Launch For Synercid In U.K.
Executive Summary
Rhone-Poulenc Rorer's injectable streptogramin antibiotic Synercid (quinupristin/dalfopristin) is expected to be launched in the U.K. by October, following approval by the Medicines Control Agency on July 29.